Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

First human tests begin for new oral compound SEP-479

NCT ID NCT07433179

Summary

This is an early-stage study to check the safety and basic effects of a new oral compound called SEP-479 in healthy adults. Researchers will give different doses to about 150 participants to see how the body processes the drug and whether it causes any side effects. The study will also test if taking the drug with food changes how it works in the body.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

Explore the condition pages connected to this study.